The Top Penny Stocks newsletter for active penny stocks investors looking for penny stocks and pink sheet stocks
Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...
Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday
Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...
UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...
Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman
GENEVA–(Marketwire – Mar 20, 2013) – Addex Therapeutics / Addex Shareholders Approve All
Board Proposals at Annual General Meeting. Processed and transmitted by
Thomson Reuters ONE.
Continue reading here: Addex Shareholders Approve All Board Proposals at Annual General Meeting
Category : Business
Thomson cancels plans to start services using Boeing’s 787 Dreamliner planes in May, transferring long-haul passengers to its 767 aircraft.
Read more: Thomson delays start of 787 flights
Category : Stocks
MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Feb 13, 2013) – MorphoSys AG /
MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics
Targeting
GPCRs. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
See the original post here: MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting GPCRs
ZURICH, SWITZERLAND–(Marketwire – Jan 16, 2013) – Barry Callebaut /
Barry Callebaut: Strong first quarter: +8.3% volume growth
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Read more: Barry Callebaut: Strong first quarter: +8.3% volume growth
Category : Stocks
GENEVA–(Marketwire – Jan 7, 2013) – Addex Therapeutics /
Addex Announces Positive Data with ADX71441 in a Pre-Clinical Transgenic
Model
of Charcot-Marie-Tooth 1A Disease
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Category : World News
BASEL, SWITZERLAND–(Marketwire – Dec 14, 2012) – Basilea Pharmaceutica AG /
Basilea reports recruitment completion of phase 3 pivotal study of
isavuconazole, an agent for the potential primary treatment of invasive and
life-threatening fungal infections
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
View original post here: Basilea reports recruitment completion of phase 3 pivotal study of isavuconazole, an agent for the potential primary treatment of invasive and life-threatening fungal infections
ZURICH, SWITZERLAND–(Marketwire – Dec 11, 2012) – Barry Callebaut /
Barry Callebaut: Previous Q1 restated figures due to consumer divestment
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Read more: Barry Callebaut: Previous Q1 restated figures due to consumer divestment
MARTINSRIE, GERMANY and MUNICH, GERMANY–(Marketwire – Dec 6, 2012) – MorphoSys AG /
MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Original post: MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
Category : World News
MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Nov 27, 2012) – MorphoSys AG /
MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of
Therapeutic Peptides. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Go here to read the rest: MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides
MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Nov 7, 2012) – MorphoSys AG /
MorphoSys AG Reports Nine Months 2012 Results
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Read the rest here: MorphoSys AG Reports Nine Months 2012 Results